4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-050182
President and CEO sold 42,000 shares at an average $24.24 ($1,018,080)
- President and CEO acquired 42,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2022-09-13 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-09-13 | Sale | −14,000 | $25.45 | $356,300 | 254,554 | D |
| Patel Sanjiv President and CEO | 2022-09-14 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-09-14 | Sale | −14,000 | $23.47 | $328,580 | 254,554 | D |
| Patel Sanjiv President and CEO | 2022-09-15 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-09-15 | Sale | −14,000 | $23.80 | $333,200 | 254,554 | D |
| Derivatives | |||||||
| Patel Sanjiv President and CEO | 2022-09-13 | Option exercise · Stock Option (Right to Buy) | −14,000 | 102,175 | D | ||
| Patel Sanjiv President and CEO | 2022-09-14 | Option exercise · Stock Option (Right to Buy) | −14,000 | 88,175 | D | ||
| Patel Sanjiv President and CEO | 2022-09-15 | Option exercise · Stock Option (Right to Buy) | −14,000 | 74,175 | D | ||
| Open-market sales · 42,000 sh · avg $24.24 · $1,018,080 | |||||||
Loading xslF345X03/doc4.xml…